Provided by Tiger Fintech (Singapore) Pte. Ltd.

BriaCell Therapeutics Corp.

4.37
-0.0900-2.02%
Mar 21 12:00 EST
Volume:8.93K
Turnover:38.75K
Market Cap:16.21M
PE:-0.34
High:4.45
Open:4.41
Low:4.20
Close:4.46
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
More
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
Loading ...

BriaCell Therapeutics Says Data Safety Monitoring Board Recommends Continuation of Phase 3 Trial in Metastatic Breast Cancer

MT Newswires Live
·
Yesterday

Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire
·
Yesterday

Briacell Therapeutics Corp reports results for the quarter ended January 31 - Earnings Summary

Reuters
·
17 Mar

Briacell Therapeutics Corp expected to post a loss of $1.12 a share - Earnings Preview

Reuters
·
14 Mar

Wedbush Initiates BriaCell Therapeutics at Outperform With $15 Price Target

MT Newswires Live
·
25 Feb

BriaCell Announces Positive Shareholder Meeting Results

TIPRANKS
·
06 Feb

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

GlobeNewswire
·
05 Feb

BriaCell Therapeutics Secures $3.05 Million in Public Offering

TIPRANKS
·
05 Feb

BriaCell Therapeutics Announces Closing of Public Offering

GlobeNewswire
·
05 Feb

BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
05 Feb

BriaCell Therapeutics Shares Hit Record Low After Public Offering News

Dow Jones
·
03 Feb

BriaCell Therapeutics Announces Public Offering to Fuel Growth

TIPRANKS
·
03 Feb

BriaCell announces common stock offering, no amount given

TIPRANKS
·
03 Feb

BriaCell Therapeutics Announces Proposed Public Offering of Common Shares

GlobeNewswire
·
03 Feb

Promising Results and Strategic Expansion Underpin Buy Rating for BriaCell Therapeutics

TIPRANKS
·
03 Feb

BriaCell Therapeutics trading resumes

TIPRANKS
·
03 Feb

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."